​

Abeona Therapeutics Ownership | Who Owns Abeona Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Abeona Therapeutics Ownership Summary

Abeona Therapeutics is owned by 5.18% insiders, and 94.81% retail investors. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.53% of its assets in Abeona Therapeutics shares.

ABEO Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAbeona Therapeutics-5.18%94.81%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustryBiotech Stocks 45.22%10.75%44.04%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20241-2,350---1---
Sep 30, 20222-94.44%153,702-99.26%21.16%--100.00%2-60.00%
Jun 30, 202236-26.53%20,889,690-35.97%142.84%11-31.25%5-66.67%
Mar 31, 2022494.26%32,623,572-20.40%221.30%16-27.27%1525.00%
Dec 31, 202147-16.07%40,985,64961.98%416.24%2222.22%12-36.84%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.30M2.53%-28.83K
Vanguard US Total Market Shares ETF1.23M2.53%-
iShares Russell 2000 ETF1.07M2.08%-
Simplify Propel Opportunities ETF558.58K1.09%-
Vanguard Institutional Extnd Mkt Idx Tr550.75K1.07%-254.92K
Kennedy Micro Cap529.32K1.03%37.89K
Fidelity Small Cap Index438.77K0.86%438.77K
iShares Russell 2000 Growth ETF358.01K0.70%-
Fidelity Extended Market Index265.32K0.52%-2.18K
abrdn Life Sciences Investors224.36K0.46%-

Recent Insider Transactions

DateNameRoleActivityValue
Nov 13, 2025Alvino Mark-Sell$71.17K
Oct 16, 2025Seshadri Vishwas Chief Executive OfficerSell$1.37K
Sep 29, 2025O'Malley Brendan M. SVP, Chief Legal OfficerSell$50.52K
Sep 30, 2025Seshadri Vishwas Chief Executive OfficerSell$130.93K
Sep 29, 2025Seshadri Vishwas Chief Executive OfficerSell$103.95K

Insider Transactions Trends

DateBuySell
2025 Q4-2
2025 Q3-15
2025 Q2-5
2025 Q1-3
2024 Q4--

ABEO Ownership FAQ

Who Owns Abeona Therapeutics?

Abeona Therapeutics shareholders are primarily institutional investors at 0.00%, followed by 5.18% insiders and 94.82% retail investors. The average institutional ownership in Abeona Therapeutics's industry, Biotech Stocks , is 45.22%, which Abeona Therapeutics falls below.

Does Blackrock own Abeona Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Abeona Therapeutics.

Who is the top mutual fund holder of Abeona Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Abeona Therapeutics shares, with 2.53% of its total shares outstanding invested in 1.3M Abeona Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools